76%
inwestorów detalicznych traci pieniądze podczas handlu CFD z tym dostawcą.
Inwestowanie wiąże się z ryzykiem i nie jest odpowiednie dla wszystkich inwestorów. Kontrakty CFD są złożonymi instrumentami i wiążą się z dużym ryzykiem szybkiej utraty środków pieniężnych z powodu dźwigni finansowej.
76%
rachunków inwestorów detalicznych notuje stratę pieniędzy podczas handlu kontraktami CFD z tym dostawcą.
Upewnij się, czy rozumiesz, jak działają kontrakty CFD, i czy możesz pozwolić sobie na wysokie ryzyko utraty pieniędzy.
76%
inwestorów detalicznych traci pieniądze podczas handlu CFD z tym dostawcą.
Inwestowanie wiąże się z ryzykiem i nie jest odpowiednie dla wszystkich inwestorów. Kontrakty CFD są złożonymi instrumentami i wiążą się z dużym ryzykiem szybkiej utraty środków pieniężnych z powodu dźwigni finansowej.
76%
rachunków inwestorów detalicznych notuje stratę pieniędzy podczas handlu kontraktami CFD z tym dostawcą.
Upewnij się, czy rozumiesz, jak działają kontrakty CFD, i czy możesz pozwolić sobie na wysokie ryzyko utraty pieniędzy.
Thermo Fisher Scientific Inc
Closed
SectorHealthcare
401.99 1.07
Overview
Share price change
24h
Min
397.95
Max
406.42
Income | -309M 1.5B |
|---|---|
Sales | -1B 10B |
P/E Sector Avg | 23.253 51.198 |
EPS | 5.15 |
Dividend yield | 0.43 |
Profit margin | 14.618 |
Employees | 125,000 |
EBITDA | -1.3B 1.7B |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +39.98% upside |
Dividend yield Sector Avg | 0.43% 2.40% |
|---|---|
Next Earnings | 23 lip 2025 |
Next Dividend date | 15 lip 2025 |
Next Ex Dividend date | 13 cze 2025 |
Market Cap | -54B 150B |
|---|---|
Previous open | 400.92 |
Previous close | 401.99 |
News Sentiment
By Acuity
34%
66%
95 / 380 Ranking in Healthcare
Technical Score
By Trading Central
Confidence
Bearish Evidence
Thermo Fisher Scientific Inc Chart
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Related News
Peer Comparison
Price change
Thermo Fisher Scientific Inc Forecast
Price Target
By TipRanks
39.98% upside
12 Months Forecast
Average 562.56 USD 39.98%
High 637 USD
Low 475 USD
Based on 19 Wall Street analysts offering 12 month price targets forThermo Fisher Scientific Inc - Dist in the last 3 months.
Sentiment
By Acuity
95 / 380 Ranking in Healthcare
News Sentiment
Bullish Evidence
Volatility
Below average
News Volume (RCV)
Above average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. It has a collaboration agreement with Mainz Biomed N.V. for the development of colorectal cancer screening product. Thermo Fisher Scientific Inc. was founded in 1956 and is headquar
